Qiming Venture Partners
Edit

Qiming Venture Partners

https://qimingvc.com/
Last activity: 08.09.2025
Active
Invests in categories: ServiceHealthTechPlatformTechnologyMedTechProductDevelopmentDrugResearchProvider
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, Seattle, Boston and the San Francisco Bay Area.

Currently Qiming Venture Partners manages nine US Dollar funds and six RMB funds with $5.9 billion in assets under management. Since our establishment, we have invested in outstanding companies in the TMT and healthcare industries at the early and growth stages.

Since our debut, we have backed over 380 fast-growing and innovative companies. Over 130 companies are already listed on NYSE, NASDAQ, HKEx, Gretai Securities Market, Shanghai Stock Exchange and Shenzhen Stock Exchange, or achieved exit through M&A and other means. There are also over 40 portfolio companies that have achieved unicorn status.

Many of our portfolio companies are today's most influential firms in their respective sectors, including Xiaomi (SEHK:1810), Meituan (SEHK:3690), Bilibili (NASDAQ:BILI, SEHK:9626), Roborock (SHSE:688169), Gan & Lee Pharmaceuticals (SHSE: 603087), Tigermed (SZSE:300347, SEHK:3347), Zai Lab (NASDAQ:ZLAB, SEHK:9688), Venus MedTech (SEHK:2500), CanSino Biologics (SEHK:6185, SHSE:688185), Schrödinger (NASDAQ:SDGR), APT Medical (SHSE:688617), Sanyou Medical (SHSE:688085), New Horizon Health (SEHK:6606), AmoyDx (SZSE:300685), Berry Genomics (SZSE:000710), SinocellTech (SHSE: 688520), WeDoctor Group, and UBTech among many others.
News
483
Portfolio
394
Mentions
124
Location: China, Shanghai
Employees: 51-200
Founded date: 2006
Investment Type: Venture Capital
Investment Stage: Series A; Series B; Series C; Series D

Portfolio 394

DateNameWebsiteTotal RaisedLocation
10.08.2025Minghui Ph...minghuipharma.com$131MChina
31.01.2024Synapsorsynapsor.com-China, Bei...
23.01.2024QuantaSingliangzizhige.com--
23.01.2024Structure ...structuretx.com$580.4MUnited Sta...
23.01.2024Novoprotei...novoprotein.com.cn--
23.01.2024Arrail Gro...arrailgroup.com-China, Bei...
23.01.2024Tuhu.comtuhu.cn$100MChina, Min...
20.01.2024one-chipone-chip.com-China, Jia...
20.01.2024Prismlabprismlab.cn--
20.01.2024M20 Genomi...m20genomics.com-China, Zhe...
Show more

News 483

DateTitleDescription
17.11.2023Clinical Proteomics Startup Complete Omics Inc. Successfully Completes Series A Financing, Exclusively Invested by Qiming Venture Partners-
11.11.2023Qiming Monthly Newsletter (October 2023)-
26.10.2023Innovation and Technology Venture Fund adds two co-investment partners-
17.10.2023Qiming Monthly Newsletter (September 2023)-
29.09.2023Qiming Venture Partners' Portfolio Company Tuhu Car Successfully Listed on the Hong Kong Stock Exchange-
06.09.2023Qiming Monthly Newsletter (July 2023)-
06.09.2023Qiming Monthly Newsletter (August 2023)-
31.08.2023Epigenic Therapeutics Announces $32M in Series A Funding-
18.08.2023July 2023 Qiming Newsletter-
30.07.2023Qiming Venture Partners Appoints James Shen as Venture Partner-
Show more

Mentions in press and media 124

DateTitleDescription
08.09.2025Epigenic Therapeutics Announces Completion of $60 Million Series B Financing to Accelerate Clinical Development of Epigenetic MedicinesSHANGHAI, Sept. 8, 2025 /PRNewswire/ -- Epigenic Therapeutics ("Epigenic"), a clinical-stage innovative drug development company, today announced the completion of a $60 million Series B round of financing led by Lapam Capital, wi...
19.08.2025Early Xiaomi Backer Qiming Slashes Fund Goal to $600 Million-
11.08.2025Minghui Pharmaceutical Raises USD 131M in Pre-IPO FinancingMinghui Pharmaceutical, a Singapore-based clinical biopharmaceutical company, raised USD 131M Pre-IPO financing. The round was led by new investors OrbiMed and co-led by Qiming Venture Partners with participation from existing investor TF C...
10.08.2025OrbiMed, Qiming lead $131m pre-IPO financing for late-stage clinical biopharma MinghuiGlobal healthcare investment firm OrbiMed and Qiming Venture Partners have jointly led a pre-IPO financing of $131 million in Minghui Pharmaceutical, a Chinese late-stage clinical biopharmaceutical company, according to a statement. Shangha...
07.08.2025Minghui Pharmaceutical Announces USD 131 Million Pre-IPO Financing to Advance Late-Stage Pipeline and Global ExpansionSHANGHAI, Aug. 7, 2025 /PRNewswire/ -- Minghui Pharmaceutical ("Minghui"), a late-stage clinical biopharmaceutical company, today announced the closing of a USD 131 million Pre-IPO financing led by new investors OrbiMed and co-led...
28.07.2025Chinese startup Z.ai launches powerful open source GLM-4.5 model family with PowerPoint creationWant smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now Another week in the summer of 2025 has begun, and in a continuation of the trend fr...
28.07.2025XellSmart Completed World's First Patient Dosing in its Registrational Clinical trial for iPSC-derived Subtype-specific Neural Cell Therapy for Spinal Cord InjurySUZHOU, China, July 28, 2025 /PRNewswire/ -- XellSmart Biopharmaceutical (Suzhou/Shanghai) Co., Ltd. achieved a significant milestone in its "world's first" China NMPA & US FDA-approved registrational clinical trial. This Phas...
28.07.2025China’s latest AI model claims to be even cheaper to use than DeepSeekStartup Z.ai, formerly known as Zhipu, announced Monday that its new GLM-4.5 AI model would cost less than DeepSeek to use. Like DeepSeek, the new model is also open source and can be downloaded for free. At about half the size of DeepSeek’...
10.07.2025Renasant Bio Raises $54.5M in Seed FundingRenasant Bio, a Berkeley, CA-based developer of disease-modifying treatments for autosomal dominant polycystic kidney disease (ADPKD), raised $54.5M in Seed funding. The round was led by 5AM Ventures, alongside other life sciences investors...
30.06.2025Qiming Venture Partners' Portfolio Company Unisound Successfully Lists on the Hong Kong Stock ExchangeSHANGHAI, June 30, 2025 /PRNewswire/ -- On June 30th, Beijing time, Unisound, a pioneer in the industrialization of AI technologies in China and a portfolio company of Qiming Venture Partners, has successfully debuted on the Hong Kong Stock...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In